GeneOnline is an international biomedical media platform that focuses on providing real-time information and in-depth analysis in the global biotechnology and pharmaceutical fields. Its core businesses include Chinese and English news websites, industry analysis reports, expert interviews, international conference reports, and biomedical marketing and public relations consulting services, and it is committed to promoting exchanges and cooperation in the global biotechnology and pharmaceutical industry.

In terms of technology, GeneOnline has launched an AI-driven biomedical database platform “BIODND”, which integrates multiple data sources and uses large language model (LLM) technology for artificial intelligence classification and labeling, greatly improving the accuracy and efficiency of information query. This platform not only supports the development of precision medicine, but also provides biotech and pharmaceutical companies with market analysis and competitor comparison functions, helping them gain advantages in new drug development and market expansion.

In the future, GeneOnline will continue to deepen its capabilities in integrating biomedical information and AI technology, expand its international influence, and work with industry partners to promote innovation and development in the biotechnology and pharmaceutical industries. Through cooperation with Dingzhe International Business Platform, Gene Online is expected to accelerate its global layout and achieve broader market penetration and value creation.

Daniel Brothers International Business Platform played an important supporting role in this symposium, assisting GeneOnline to conduct in-depth cooperation and exchanges with industry leaders and investment institutions, and assisting it in conducting comprehensive strategic planning in commercialization and market expansion.